Peter Simmons
Overview
Explore the profile of Peter Simmons including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
18
Citations
129
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Simmons P, Dalton H
Aust J Rural Health
. 2022 Oct;
31(2):171-181.
PMID: 36226333
Objective: To explore the influences of rurality on small business owner mental well-being and approaches to managing stress and mental well-being. Design: Semistructured interviews with small businesspeople. Concepts of salutogenesis...
2.
Bickerstaff K, Simmons P
Geoforum
. 2020 Apr;
40(5):864-872.
PMID: 32226097
There is now a substantial body of sociocultural research that has investigated the ways in which specific communities living in physical proximity with a variety of polluting or hazardous technological...
3.
Byrne K, Simmons P
J Cardiothorac Vasc Anesth
. 2020 Feb;
34(5):1235-1237.
PMID: 32033889
No abstract available.
4.
Downie L, Hom M, Berdy G, El-Harazi S, Verachtert A, Tan J, et al.
Ocul Surf
. 2019 Nov;
18(1):148-157.
PMID: 31734510
Purpose: To evaluate the efficacy and safety of a nano-emulsion artificial tear (OM3) containing carboxymethylcellulose (CMC) and glycerin, flaxseed oil and castor oil, and three osmoprotectants (levocarnitine, erythritol, and trehalose)...
5.
Lievens C, Berdy G, Douglass D, Montaquila S, Lin H, Simmons P, et al.
Cont Lens Anterior Eye
. 2018 Dec;
42(4):443-449.
PMID: 30573298
Purpose: In a randomized, controlled clinical trial, two lubricant artificial tear formulations with enhanced viscosity were compared: an investigational product at the time, containing carboxymethylcellulose 1.0% and glycerin 0.9% (CMC-GLY)...
6.
Martin E, Oliver K, Pearce E, Tomlinson A, Simmons P, Hagan S
Cytokine
. 2018 Feb;
105:37-44.
PMID: 29452970
Purpose: Three tear supplements were compared for their effects on the signs, symptoms and inflammatory status of subjects with dry eye disease. Assessments were made before and after both 2...
7.
Nichols J, Lievens C, Bloomenstein M, Liu H, Simmons P, Vehige J
Optom Vis Sci
. 2016 Jun;
93(8):979-86.
PMID: 27254807
Purpose: This study compared a new contact lens rewetting drop containing both carboxymethylcellulose and hyaluronic acid (CMC-HA) with a standard drop containing carboxymethylcellulose only (CMC). Symptoms of discomfort typical in...
8.
Guiza F, Simmons P, Burgess J, McCall M
Disasters
. 2015 Aug;
40(1):112-33.
PMID: 26271745
The dominant paradigm in disaster risk reduction (DRR) policies has been seriously contested because of its reliance on interventions based on technocratic expertise. In the Mexican context, the influence of...
9.
Khandekar N, Willcox M, Shih S, Simmons P, Vehige J, Garrett Q
Mol Vis
. 2013 Sep;
19:1945-56.
PMID: 24068862
Purpose: To characterize the osmoprotective properties of L-carnitine on human corneal epithelial cell volume and apoptosis during hyperosmotic stress. Methods: Human corneal limbal epithelial (HCLE) cells were exposed to culture...
10.
Garrett Q, Khandekar N, Shih S, Flanagan J, Simmons P, Vehige J, et al.
Exp Eye Res
. 2012 Dec;
108:33-41.
PMID: 23246691
Elevated tear osmolarity is one of the key pathological factors in dry eye leading to ocular discomfort associated with damage to the ocular surface and inflammation. The aim of this...